Induction chemotherapy with mitomycin, vindesine, and cisplatin for stage IIIA (T1-3, N2) unresectable non-small-cell lung cancer: Final results of the Toronto phase II trial
Ronald L. Burkes, Frances A. Shepherd, Martin E. Blackstein, Melvin E. Goldberg, Paul F. Waters, G. Alexander Patterson, Thomas Todd, F. Griffith Pearson, Donald Jones, Samina Farooq, John McGlaughlin, Robert J. Ginsberg
Dive into the research topics of 'Induction chemotherapy with mitomycin, vindesine, and cisplatin for stage IIIA (T1-3, N2) unresectable non-small-cell lung cancer: Final results of the Toronto phase II trial'. Together they form a unique fingerprint.